Putnam Multi-Cap Value Fund

2 / 5 Stars
5 5 3 4 4
Zacks Investment Research
1 (Strong Buy)
Standard & Poor's
3 / 5 Stars
B+ (Buy)

#20 in Mid-Cap Value

U.S. News evaluated 112 Mid-Cap Value Funds. Our list highlights the top-rated funds for long-term investors based on the ratings of leading fund industry researchers.

See all Putnam funds

See full Mid-Cap Value rankings

See more fund rankings


The fund has returned 31.31 percent over the past year, 17.54 percent over the past three years, 21.34 percent over the past five years, and 9.34 percent over the past decade.

Trailing Returns Updated 06.30.2014
Year to date 7.7%
1 Year 31.3%
3 Years (Annualized) 17.5%
5 Years (Annualized) 21.3%
10 Years (Annualized) 9.3%

See more PMVAX performance


The investment seeks capital appreciation and, as a secondary objective, current income. The fund invests mainly in common stocks of U.S. companies of any size, with a focus on value stocks. Value stocks are issued by companies that the adviser believes are currently undervalued by the market. The adviser may consider, among other factors, a company's valuation, financial strength, and growth potential, competitive position in its industry, projected future earnings, cash flows and dividends when deciding whether to buy or sell investments.


Fees are Low compared to funds in the same category.
Putnam Multi-Cap Value Fund has an expense ratio of 1.11 percent.

See more PMVAX fees


Risk is Above Average compared to funds in the same category according to Morningstar.

See more PMVAX risk